✦ LIBER ✦

2 -Chloro-deoxyadenosine therapy for giant lymph node hyperplasia

✍ Scribed by Louise Bordeleau; Christopher Bredeson; Saul Markman

Book ID: 114714311
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 332 KB
Volume: 91
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1995.tb05366.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Giant lymph node hyperplasia: Persistenc

Giant lymph node hyperplasia: Persistence of symptoms for 15 years

✍ D. H. Moir; T. Choy; W. R. Dalton 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Unexpected uptake of technetium 99m hexa

Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease)

✍ Cumali Aktolun; Hikmet Bayhan; Bülent Celasun; Metin K. Kir 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 401 KB

The case of a patient with giant lymph node hyperplasia of the mediastinum who unexpectedly showed focal uptake of technetium 99m hexakis-2-methoxyisobutylisonitrile (99mTc-MIBI) is presented in this article. The patient was included in our research programme of tumour imaging with 99mTc-MIBI becaus

Giant lymph node hyperplasia: A review o

Giant lymph node hyperplasia: A review of literature and report of two cases of plasma cell variant responding to radiation therapy

✍ Donald G. Nordstrom; Hamed H. Tewfik; Howard B. Latourette 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 737 KB

Outcome for lymph node dissection negati

Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06

✍ Gerald E. Hanks; Sucha Asbell; John M. Krall; Carlos A. Perez; Scotte Doggett; P 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Ten year outcome for lymph node dissecti

Ten year outcome for lymph node dissection negative T1b,2 (A-2,B) prostate cancer treated with external beam radiation therapy in RTOG 77-06

✍ G.E. Hanks; S.O Asbel; J.M. Krall; C.A. Perez; R.L.S. Doggett; P. Rubin; W.T. Sa 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Adjuvant trastuzumab reduces locoregiona

Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer

✍ Ana P. Kiess; Heather L. McArthur; Kathleen Mahoney; Sujata Patil; Patrick G. Mo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB